Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 21, 2026
Functional response, in T2 severe asthmatic patients, treated with mepolizumab for 2 yearsMarco Bonavia, Benedetta Bondi, Diego Bagnasco, et al.
Journal of Asthma and Allergy|March 3, 2021
Real-World Experience with Benralizumab in Patients with Severe Eosinophilic Asthma: A Case SeriesFrancesco Menzella, Marco Bonavia, Matteo Bonini, et al.
Respiratory Care|December 22, 2016
Time Required to Rectify Inhaler Errors Among Experienced Subjects With Faulty TechniqueAndrea S Melani, Marco Bonavia, Eliuccia Mastropasqua, et al.
Respiratory Medicine|March 4, 2011
Inhaler mishandling remains common in real life and is associated with reduced disease controlAndrea S Melani, Marco Bonavia, Vincenzo Cilenti, et al.
Respiratory Medicine|February 10, 2009
Office spirometry can improve the diagnosis of obstructive airway disease in primary care settingGabriella Averame, Marco Bonavia, Paolo Ferri, et al.
International Journal of Cardiology|July 26, 2021
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-upPiero Clavario, Vincenzo De Marzo, Roberta Lotti, et al.
Pulmonary Pharmacology & Therapeutics|September 2, 2019
One year of mepolizumab. Efficacy and safety in real-life in ItalyDiego Bagnasco, Marco Caminati, Francesco Menzella, et al.
Respiratory Medicine|September 12, 2020
Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposisDiego Bagnasco, Luisa Brussino, Marco Bonavia, et al.
The World Allergy Organization Journal|October 1, 2020
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)Giorgio Walter Canonica, Francesco Blasi, Pierluigi Paggiaro, et al.
Pageof 2